Proinflammatory Microenvironment in Adenocarcinoma Tissue of Colorectal Carcinoma.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
19 Sep 2024
Historique:
received: 19 08 2024
revised: 12 09 2024
accepted: 17 09 2024
medline: 29 9 2024
pubmed: 28 9 2024
entrez: 28 9 2024
Statut: epublish

Résumé

Cancer-promoting proinflammatory microenvironment influences colorectal cancer (CRC) development. We examined the biomarkers of inflammation, intestinal differentiation, and DNA activity correlated with the clinical parameters to observe progression and prognosis in the adenocarcinoma subtype of CRC. Their immunohistology, immunoblotting, and RT-PCR analyses were performed in the adenocarcinoma and neighboring healthy tissues of 64 patients with CRC after routine colorectal surgery. Proinflammatory nuclear factor kappa B (NFκB) signaling as well as interleukin 6 (IL-6) and S100 protein levels were upregulated in adenocarcinoma compared with nearby healthy colon tissue. In contrast to nitrotyrosine expression, the oxidative stress marker 8-Hydroxy-2'-deoxyguanosine (8-OHdG) was increased in adenocarcinoma tissue. Biomarkers of intestinal differentiation β-catenin and mucin 2 (MUC2) were inversely regulated, with the former upregulated in adenocarcinoma tissue and positively correlated with tumor marker CA19-9. Downregulation of MUC2 expression correlated with the increased 2-year survival rate of patients with CRC. Proliferation-related mammalian target of rapamycin (mTOR) signaling was activated, and Ki67 frequency was three-fold augmented in positive correlation with metastasis and cancer stage, respectively. Conclusion: We demonstrated a parallel induction of oxidative stress and inflammation biomarkers in adenocarcinoma tissue that was not reflected in the neighboring healthy colon tissue of CRC. The expansiveness of colorectal adenocarcinoma was confirmed by irregular intestinal differentiation and elevated proliferation biomarkers, predominantly Ki67. The origin of the linked inflammatory factors was in adenocarcinoma tissue, with an accompanying systemic immune response.

Identifiants

pubmed: 39337548
pii: ijms251810062
doi: 10.3390/ijms251810062
pii:
doi:

Substances chimiques

Mucin-2 0
Biomarkers, Tumor 0
TOR Serine-Threonine Kinases EC 2.7.11.1
beta Catenin 0
MUC2 protein, human 0
NF-kappa B 0
Interleukin-6 0
MTOR protein, human EC 2.7.1.1
8-Hydroxy-2'-Deoxyguanosine 88847-89-6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ministry of Science, Technological Development, and Innovation of the Republic of Serbia
ID : 451-03-66/2024-03/200015

Auteurs

Slobodan Todorović (S)

University Hospital Medical Center Bežanijska Kosa, Faculty of Medicine, University of Belgrade, Dr. Žorža Matea bb, 11080 Belgrade, Serbia.

Miljan S Ćeranić (MS)

University Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Pasterova 2, 11000 Belgrade, Serbia.
Faculty of Medicine, University of Belgrade, Dr. Subotića starijeg 8, 11000 Belgrade, Serbia.

Borislav Tošković (B)

University Hospital Medical Center Bežanijska Kosa, Faculty of Medicine, University of Belgrade, Dr. Žorža Matea bb, 11080 Belgrade, Serbia.
Faculty of Medicine, University of Belgrade, Dr. Subotića starijeg 8, 11000 Belgrade, Serbia.

Miloš Diklić (M)

Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, Dr. Subotica 4, 11129 Belgrade, Serbia.

Olivera Mitrović Ajtić (O)

Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, Dr. Subotica 4, 11129 Belgrade, Serbia.

Tijana Subotički (T)

Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, Dr. Subotica 4, 11129 Belgrade, Serbia.

Milica Vukotić (M)

Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, Dr. Subotica 4, 11129 Belgrade, Serbia.

Teodora Dragojević (T)

Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, Dr. Subotica 4, 11129 Belgrade, Serbia.

Emilija Živković (E)

Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, Dr. Subotica 4, 11129 Belgrade, Serbia.

Svetlana Oprić (S)

University Hospital Medical Center Bežanijska Kosa, Faculty of Medicine, University of Belgrade, Dr. Žorža Matea bb, 11080 Belgrade, Serbia.

Miodrag Stojiljkovic (M)

University Hospital Medical Center Bežanijska Kosa, Faculty of Medicine, University of Belgrade, Dr. Žorža Matea bb, 11080 Belgrade, Serbia.

Jasna Gačić (J)

University Hospital Medical Center Bežanijska Kosa, Faculty of Medicine, University of Belgrade, Dr. Žorža Matea bb, 11080 Belgrade, Serbia.

Nataša Čolaković (N)

University Hospital Medical Center Bežanijska Kosa, Faculty of Medicine, University of Belgrade, Dr. Žorža Matea bb, 11080 Belgrade, Serbia.

Bogdan Crnokrak (B)

University Hospital Medical Center Bežanijska Kosa, Faculty of Medicine, University of Belgrade, Dr. Žorža Matea bb, 11080 Belgrade, Serbia.

Vladan P Čokić (VP)

Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, Dr. Subotica 4, 11129 Belgrade, Serbia.

Dragoslava Đikić (D)

Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, Dr. Subotica 4, 11129 Belgrade, Serbia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH